BR112016021408A2 - métodos para o tratamento da doença de alzheimer utilizando compostos derivados de 6-estradiol substituído - Google Patents

métodos para o tratamento da doença de alzheimer utilizando compostos derivados de 6-estradiol substituído

Info

Publication number
BR112016021408A2
BR112016021408A2 BR112016021408A BR112016021408A BR112016021408A2 BR 112016021408 A2 BR112016021408 A2 BR 112016021408A2 BR 112016021408 A BR112016021408 A BR 112016021408A BR 112016021408 A BR112016021408 A BR 112016021408A BR 112016021408 A2 BR112016021408 A2 BR 112016021408A2
Authority
BR
Brazil
Prior art keywords
estradiol
disease
substituted
methods
treating alzheimer
Prior art date
Application number
BR112016021408A
Other languages
English (en)
Portuguese (pt)
Inventor
Steven H Nye
James G Yarger
Original Assignee
Endece Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endece Llc filed Critical Endece Llc
Publication of BR112016021408A2 publication Critical patent/BR112016021408A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112016021408A 2014-03-19 2015-03-19 métodos para o tratamento da doença de alzheimer utilizando compostos derivados de 6-estradiol substituído BR112016021408A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461955578P 2014-03-19 2014-03-19
PCT/US2015/021538 WO2015143201A2 (en) 2014-03-19 2015-03-19 6-substituted estradiol derivatives for the treatment of alzheimer's disease

Publications (1)

Publication Number Publication Date
BR112016021408A2 true BR112016021408A2 (pt) 2017-12-19

Family

ID=54141046

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016021408A BR112016021408A2 (pt) 2014-03-19 2015-03-19 métodos para o tratamento da doença de alzheimer utilizando compostos derivados de 6-estradiol substituído

Country Status (11)

Country Link
US (1) US20150265630A1 (https=)
EP (1) EP3119402A4 (https=)
JP (1) JP2017512769A (https=)
KR (1) KR20160136363A (https=)
CN (1) CN106255501A (https=)
AU (2) AU2015231172A1 (https=)
BR (1) BR112016021408A2 (https=)
CA (1) CA2940536A1 (https=)
MX (1) MX2016012045A (https=)
SG (1) SG11201607693WA (https=)
WO (1) WO2015143201A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020247407A1 (en) * 2019-06-03 2020-12-10 Aihol Corporation Hyaluronan conjugates and uses thereof
US20210024568A1 (en) * 2019-07-23 2021-01-28 Endece Llc Methods for modulation of lipoprotein lipase and apolipoprotein c2 expression and/or activity in the treatment of peripheral and central nervous system tissue disease states

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10174070B2 (en) * 2005-09-30 2019-01-08 Endece Llc 6-substituted estradiol derivatives and methods of use
US20080200441A1 (en) * 2007-02-14 2008-08-21 University Of Southern California Estrogen receptor modulators associated pharmaceutical compositions and methods of use
CN106420767A (zh) * 2011-03-21 2017-02-22 安德斯有限责任公司 用于神经轴突的髓鞘再生的6‑取代的雌二醇衍生物

Also Published As

Publication number Publication date
CN106255501A (zh) 2016-12-21
JP2017512769A (ja) 2017-05-25
EP3119402A2 (en) 2017-01-25
SG11201607693WA (en) 2016-10-28
KR20160136363A (ko) 2016-11-29
EP3119402A4 (en) 2017-11-01
AU2015231172A1 (en) 2016-09-08
CA2940536A1 (en) 2015-09-24
MX2016012045A (es) 2017-01-19
WO2015143201A2 (en) 2015-09-24
AU2018201003A1 (en) 2018-03-01
US20150265630A1 (en) 2015-09-24

Similar Documents

Publication Publication Date Title
IL285722A (en) Methods for treating alzheimer's disease
IL281633A (en) Methods for treating Huntington's disease
IL283561B (en) Methods for treating ocular diseases
IL261935A (en) Methods of treatment of cholestatic diseases
IL257252A (en) Methods of treating fgf21-associated disorders
IL247085A0 (en) Methods for treating Alzheimer's disease
IL247003B (en) Isoindoline compositions and methods for treating neurodegenerative disease
IL269174A (en) Methods for treating complement-mediated diseases and disorders
EP3298448A4 (en) OPTOGENETIC MICROSCOPE
IL263433A (en) Methods for treating alzheimer's disease
ZA201605341B (en) Methods of treating alzheimer's disease
BR112016016792A2 (pt) Aparelho para tratamento de vestuário
HRP20190194T1 (hr) 17a,21-diesteri korteksolona, namijenjeni liječenju tumora
DK3148529T3 (da) Forbindelser til behandling af hjernecancer
BR112016022976A2 (pt) Métodos para o tratamento de hcv
IL265751B (en) Immunogenic compounds for cancer therapy
IL263161B (en) New compounds for the treatment of parasitic diseases
PT3463351T (pt) Tratamento para a doença de parkinson
IL257596A (en) Methods for treatment of polycystic kidney disease
DK3855181T3 (da) Forbindelser til behandling af lipofuscinrelaterede sygdomme
BR112016015712A2 (pt) método de tratamento de doenças hepáticas.
FR3019967B1 (fr) Procede d'ostreiculture ameliore
LT3413870T (lt) Igmesinas, skirtas panaudoti alzheimerio ligos gydymui
BR112016021408A2 (pt) métodos para o tratamento da doença de alzheimer utilizando compostos derivados de 6-estradiol substituído
EP3244897A4 (en) Methods for treating alzheimer's disease

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2558 DE 14/01/2020.